CoreCap Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

CoreCap Advisors’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$74	Hold	6	–	–	﹤0.01%	3073
2026 Q2	$40	Buy	6 +3	+100%	+$15	﹤0.01%	3128
2026 Q1	$14	Hold	3	–	–	﹤0.01%	2913
2025 Q4	$25	Hold	3	–	–	﹤0.01%	2924
2025 Q3	$18	Hold	3	–	–	﹤0.01%	2772
2025 Q2	$25	Hold	3	–	–	﹤0.01%	2728
2025 Q1	$19	Hold	3	–	–	﹤0.01%	3111
2024 Q4	$26	Hold	3	–	–	﹤0.01%	2816
2024 Q3	$27	Hold	3	–	–	﹤0.01%	2596
2024 Q2	$35	Hold	3	–	–	﹤0.01%	1564
2024 Q1	$54	Buy	+3	New	+$43	﹤0.01%	2473
2022 Q4	$39	Buy	+3	New	+$49	﹤0.01%	2345
2022 Q3	–	Sell	-3	Closed	–	–	866
2022 Q2	$0	Buy	+3	New	+$73	﹤0.01%	2157

Other funds holding HELP

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

KTC

Kentucky Trust Company Danville, Kentucky $200M AUM 22.53% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Atlantic Edge Private Wealth Management Jacksonville, Florida $487M AUM 24.51% 1-Year Est. Return

NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return

City State Bank Norwalk, Iowa $441M AUM 23.97% 1-Year Est. Return

CoreCap Advisors's HELP Position: Q3 2026 in Review

CoreCap Advisors held its Helus Pharma Inc. Common Stock (HELP) position steady in Q3 2026 at 6 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

CoreCap Advisors first reported a position in HELP in Q2 2022 and has held it in 13 quarters since. 10 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

CoreCap Advisors held 6 shares of Helus Pharma Inc. Common Stock worth $74 as of Q3 2026.
CoreCap Advisors left its Helus Pharma Inc. Common Stock share count unchanged in Q3 2026.
Helus Pharma Inc. Common Stock made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #3073 holding.
CoreCap Advisors first reported a position in Helus Pharma Inc. Common Stock in Q2 2022 and has held it in 13 quarters since.
10 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.